Novartis stops study of iscalimab in kidney transplant patients
ZURICH (SWITZERLAND) - Novartis has halted a clinical trial of CFZ533 (iscalimab) in kidney transplant patients after ...
Read moreZURICH (SWITZERLAND) - Novartis has halted a clinical trial of CFZ533 (iscalimab) in kidney transplant patients after ...
Read moreZURICH (SWITZERLAND) - Switzerland suffered one of its heaviest rainfalls on record during a thunderstorm that ...
Read moreZURICH (SWITZERLAND) - The biggest crematorium of Switzerland is bracing for a new spike in the ...
Read more